CyberKnife Radiosurgery Success Rate in India
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
CyberKnife Radiosurgery Success Rate in India
Understanding the CyberKnife Radiosurgery success rate in India is crucial for patients considering this advanced treatment. Outcomes are complex, varying significantly based on the specific condition being treated, tumor characteristics, and individual patient health profiles. India has established itself as a prominent destination for high-precision radiosurgery, with increasing access to sophisticated technology and expert medical teams.
Clinical data and treatment-level evaluations in India indicate a nuanced picture of success, reflecting international standards for this specialized therapy. These rates are derived from aggregated patient outcomes across various institutions, acknowledging that results can differ based on the precise CyberKnife application, disease stage, and overall patient factors. This information aids in setting realistic expectations.
Defining Success in CyberKnife Radiosurgery Outcomes
For CyberKnife Radiosurgery, 'success' typically refers to several key indicators, including local tumor control, symptom alleviation, and maintaining or improving a patient's quality of life. Understanding the CyberKnife Radiosurgery recovery rate in India involves assessing sustained health improvements and managing potential recurrence. Distinguishing between short-term treatment effects and sustained benefits over years is vital for comprehensive understanding, aiming for long-term progression-free survival.
CyberKnife Radiosurgery Success Rate in India Breakdown
CyberKnife Radiosurgery success rate in India varies depending on the specific application, disease type, and individual patient factors. Here is a general overview.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Intracranial Tumors | Benign & Metastatic Brain Lesions | 85%–98% | High local tumor control; symptom stability |
| Spinal Tumors | Primary & Metastatic Spine Lesions | 80%–95% | Effective local control; pain reduction |
| Early-Stage Lung Cancer | Small, localized non-small cell lung cancer | 75%–90% | Excellent local control; progression-free outcomes |
| Prostate Cancer | Low & Intermediate Risk Prostate Cancer | 90%–97% | Disease-free survival; minimal side effects |
| Pancreatic Cancer | Localized disease or palliation | 60%–75% | Local disease control; improved pain management |
Stage-Wise and Age-Wise CyberKnife Radiosurgery Survival Rate in India
The CyberKnife Radiosurgery survival rate by age in India, and variations based on disease stage, are critical considerations influencing patient prognosis. Globally, clinical data consistently indicates that earlier detection and treatment, coupled with a younger patient age and better overall health, generally lead to more favorable outcomes. These trends in stage wise CyberKnife Radiosurgery survival rate in India align closely with internationally observed clinical findings and research.
| Age Group / Patient Category | Typical Disease Stage | CyberKnife Survival Rate Range (%) |
|---|---|---|
| Younger Adults (<65 years) | Early to Intermediate Stage | 85%–95% |
| Older Adults (>65 years) | Early to Intermediate Stage | 75%–90% |
| Any Age Group | Locally Advanced Disease | 60%–75% |
| Any Age Group | Recurrent Disease | 50%–70% |
CyberKnife Radiosurgery Outcomes: India vs. Global Standards
The CyberKnife Radiosurgery survival rate in India is increasingly comparable with leading international centers, particularly when similar patient selection criteria, advanced technological infrastructure, and experienced medical expertise are consistently applied. Many leading centers across India adhere to rigorous global protocols, contributing to outcomes that reflect international benchmarks for this highly specialized treatment modality.
| Country / Region | CyberKnife Local Control Rate Range (%) |
|---|---|
| India | 75%–95% |
| United States | 80%–97% |
| Germany | 78%–96% |
| United Kingdom | 75%–94% |
| Singapore | 79%–95% |
| South Korea | 77%–95% |
| Thailand | 70%–90% |
Please note that reported success rates are indicative, not guaranteed. Individual outcomes vary based on patient condition, disease progression, and specific treatment protocols.
Factors Influencing CyberKnife Radiosurgery Success Rate in India
- Tumor characteristics, including size, location, and type
- Disease stage at the time of diagnosis and treatment initiation
- Patient's overall health, age, and presence of co-morbidities
- Previous treatments received and their impact on current condition
- Accuracy of tumor targeting and radiation dose delivery
- Expertise of the medical team and technological precision of the CyberKnife system
Data Sources and Methodologies for CyberKnife Outcomes
- Analysis of national cancer registries and multi-institutional clinical databases
- Comprehensive meta-analyses and peer-reviewed medical literature
- Aggregated outcome data from specialized CyberKnife treatment centers
- World Health Organization (WHO) and International Agency for Research on Cancer (IARC) reports
- Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols.
Informed Decisions for Your Health Journey
Understanding these outcome statistics empowers patients to make informed decisions about CyberKnife Radiosurgery. Discussing individual circumstances with a healthcare professional ensures personalized insights into potential treatment pathways and expected results.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.